Checked
CDT Equity Inc.
Nasdaq: CDT, Nasdaq: CDTTW · Pharmaceutical Preparations · Naples, FL
- Net income
- -$39.22M
- Total assets
- $5.65M
- Diluted EPS
- -$1177.89
Company details
As reported to the SEC
- SEC CIK
- 1896212
- Stock
- Nasdaq: CDT, Nasdaq: CDTTW
- Industry (SIC)
- Pharmaceutical Preparations (2834)
- Headquarters
- 4851 Tamiami Trail North, Suite 200, Naples, FL 34103
- Incorporated in
- Delaware
- Fiscal year end (SEC record)
- December 31
- Filer status
- , Emerging growth company
- Phone
- (646) 491-9132
- Employer ID (EIN)
- 87-3272543
- Last annual report
- 04/15/2026
- Last quarterly report
- 08/12/2026
Formerly: CONDUIT PHARMACEUTICALS INC. (until 08/07/2025); Murphy Canyon Acquisition Corp. (until 09/21/2023)
Annual financials
U.S. dollars, as tagged in each annual report's XBRL data. Later restatements replace earlier numbers. Select a date to open the filing.
| Fiscal year ended | 12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 |
|---|---|---|---|---|
| Operating income | -$36.76M | -$15.42M | -$5.26M | -$3.16M |
| Net income | -$39.22M | -$17.8M | -$535K | -$4.89M |
| Diluted earnings per share | -$1177.89 | -$61598.62 | -$8.92 | -$0.13 |
| Research and development | $5.05M | $3.38M | $90K | $37K |
| Total assets | $5.65M | $4.19M | $7.22M | $5K |
| Total liabilities | $12.82M | $10.99M | $7.68M | $10.09M |
| Shareholders' equity | -$7.17M | -$6.79M | -$457K | -$10.09M |
| Cash and cash equivalents | $1.51M | $554K | $4.23M | $345.8K |
| Cash from operations | -$15.55M | -$9.68M | -$7.72M | -$2.27M |
| Capital expenditures | Not reported | $51K | Not reported | Not reported |
Recent filings
104 recent filings on record; insider ownership forms (3, 4, 5 and 144) are not listed here
Swipe the table sideways to see more columns.
8 insider ownership reports (Forms 3, 4, 5 and 144) were filed about CDT Equity Inc. in the last 12 months. They list trades by officers, directors and large holders; see them on SEC EDGAR.
Other pharmaceutical preparations
Swipe the table sideways to see more columns.
| Company | Headquarters | Revenue | Net income |
|---|---|---|---|
| Johnson & JohnsonJNJ | New Brunswick, NJ | $94.19B | $26.8B |
| Eli Lilly & CoLLY | Indianapolis, IN | $65.18B | $20.64B |
| Merck & Co., Inc.MRK | Rahway, NJ | $65.01B | $18.25B |
| Pfizer IncPFE | New York, NY | $62.58B | $7.77B |
| AbbVie Inc.ABBV | North Chicago, IL | $61.16B | $4.23B |
| Astrazeneca PLCAZN | Cambridge, United Kingdom | $58.74B | $10.22B |
| Bristol Myers Squibb CoBMY | Princeton, NJ | $48.19B | $7.05B |
| Abbott LaboratoriesABT | Abbott Park, IL | $44.33B | $6.52B |
Profile refreshed Oct 26, 2026; financials refreshed Oct 22, 2026.
Frequently asked questions
- What is CDT Equity Inc.'s CIK number?
- CDT Equity Inc.'s SEC Central Index Key (CIK) is 1896212.
- What is CDT Equity Inc.'s stock ticker?
- CDT Equity Inc. trades as Nasdaq: CDT, Nasdaq: CDTTW.
- When does CDT Equity Inc.'s fiscal year end?
- CDT Equity Inc.'s fiscal year end on file with the SEC is December 31; its most recent fiscal year ended Dec 31, 2025.
- Where is CDT Equity Inc. headquartered?
- CDT Equity Inc.'s principal executive office on file with the SEC is in Naples, FL.
Source: U.S. Securities and Exchange Commission, EDGAR submissions and XBRL company facts · Last updated 10/26/2026